(S1 (S (NP (NN Foxp3)) (VP (VBZ Represses) (NP (JJ Retroviral) (NN Transcription)) (PP (IN by) (S (VP (VBG Targeting) (NP (DT Both) (NP (NP (NN NF-kappaB)) (CC and) (NP (NN CREB))) (NNS Pathways))))))))
(S1 (S (S (S (NP (NN Forkhead) (NN box) (-LRB- -LRB-) (NN Fox) (-RRB- -RRB-) (NN /winged-helix) (NN transcription) (NNS factors)) (VP (VBP regulate) (NP (NP (JJ multiple) (NNS aspects)) (PP (IN of) (NP (JJ immune) (NN responsiveness)))))) (CC and) (S (NP (NN Foxp3)) (VP (VBZ is) (VP (VBN recognized) (PP (IN as) (NP (NP (DT an) (JJ essential) (JJ functional) (NN marker)) (PP (IN of) (NP (JJ regulatory) (NN T) (NNS cells))))))))) (. .)))
(S1 (S (S (ADVP (RB Herein)) (NP (PRP we)) (VP (VBP describe) (NP (NP (JJ downstream) (NN signaling) (NNS pathways)) (VP (VBN targeted) (PP (IN by) (NP (NP (NN Foxp3)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (ADVP (RB negatively)) (VP (NN impact) (NP (JJ retroviral) (NN pathogenesis)))))))))))) (. .)))
(S1 (S (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN Foxp3))) (PP (IN in) (NP (NP (NN HEK) (NN 293T)) (CC and) (NP (VBN purified) (JJ CD4+) (NN T) (NNS cells))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (ADJP (ADJP (JJ dose-dependent)) (CC and) (ADJP (JJ time-dependent))) (NN decrease)) (PP (IN in) (NP (NP (JJ basal) (NNS levels)) (PP (IN of) (NP (NP (NP (JJ nuclear) (NN factor-kappaB)) (PRN (-LRB- -LRB-) (NP (NN NF-kappaB)) (-RRB- -RRB-))) (NN activation))))))))) (. .)))
(S1 (S (S (NP (NP (NN Deletion)) (PP (IN of) (NP (NP (DT the) (JJ carboxyl-terminal) (NN forkhead) (-LRB- -LRB-) (NN FKH) (-RRB- -RRB-) (NN domain)) (, ,) (ADJP (JJ critical) (PP (IN for) (NP (NP (JJ nuclear) (NN localization)) (CC and) (NP (JJ DNA-binding) (NN activity))))) (, ,)))) (VP (VBD abrogated) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN Foxp3))) (S (VP (TO to) (VP (VB suppress) (NP (NN NF-kappaB) (NN activity)) (PP (PP (IN in) (NP (NN HEK) (NN 293T) (NNS cells))) (, ,) (CC but) (PP (RB not) (IN in) (NP (NP (NN Jurkat)) (CC or) (NP (JJ primary) (JJ human) (JJ CD4+) (NN T) (NNS cells))))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (ADVP (RB further)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN Foxp3)) (VP (VBD suppressed) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (NP (NP (CD two) (JJ human) (JJ retroviral) (NNS promoters)) (PRN (-LRB- -LRB-) (NP (NP (NN HIV-1)) (CC and) (NP (NP (JJ human) (NN T) (NN cell) (NN lymphotropic) (NN virus) (NN type) (CD I)) (PRN (-LRB- -LSB-) (NP (NN HTLV-I)) (-RRB- -RSB-)))) (-RRB- -RRB-))) (VP (VBG utilizing) (NP (NP (ADJP (JJ NF-kappaB-dependent))) (CC and) (NP (NN NF-kappaB-independent)) (NP (NNS mechanisms)))))))))))) (. .)))
(S1 (S (S (NP (NP (NN Examination)) (PP (IN of) (NP (DT the) (JJ latter)))) (VP (VBD identified) (NP (NP (NP (DT the) (JJ cAMP-responsive) (NN element) (NN binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CREB)) (-RRB- -RRB-))) (NN pathway)) (PP (IN as) (NP (NP (DT a) (NN target)) (PP (IN of) (NP (NN Foxp3))))))) (. .)))
(S1 (S (ADVP (RB Finally)) (, ,) (NP (NP (NN comparison)) (PP (IN of) (NP (DT the) (JJ percent) (NN Foxp3+CD4+CD25+) (NN T) (NNS cells))) (PP (TO to) (NP (NP (DT the) (NN HTLV-I) (JJ proviral) (NN load)) (PP (IN in) (NP (NP (JJ HTLV-I-infected) (JJ asymptomatic) (NNS carriers)) (CC and) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ HTLV-I-associated) (JJ myelopathy/tropical) (JJ spastic) (NN paraparesis))))))))) (VP (VBD suggested) (SBAR (IN that) (S (NP (JJ high) (NN Foxp3) (NN expression)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ low) (JJ proviral) (NN load)) (CC and) (NP (NP (NN absence)) (PP (IN of) (NP (NN disease))))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (NP (NP (DT an) (VBN expanded) (NN role)) (PP (IN for) (NP (NN Foxp3))) (PP (IN in) (S (VP (VBG regulating) (NP (ADJP (ADJP (JJ NF-kappaB-)) (CC and) (ADJP (JJ CREB-dependent))) (ADJP (ADJP (JJ cellular)) (CC and) (ADJP (JJ viral))) (NN gene) (NN expression)))))))) (. .)))
